Evaluation of a Novel Liquid Fiducial Marker, BioXmark(®), for Small Animal Image-Guided Radiotherapy Applications

BioXmark(®) (Nanovi A/S, Denmark) is a novel fiducial marker based on a liquid, iodine-based and non-metallic formulation. BioXmark(®) has been clinically validated and reverse translated to preclinical models to improve cone-beam CT (CBCT) target delineation in small animal image-guided radiotherap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Brown, Kathryn H., Ghita, Mihaela, Schettino, Giuseppe, Prise, Kevin M., Butterworth, Karl T.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280978/
https://ncbi.nlm.nih.gov/pubmed/32443537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051276
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky